Abstract
Emerging evidences exposed that long noncoding RNAs (lncRNAs) play important roles in various tumor progression including breast cancer (BC). However, the role of lncRNA ADP-dependent glucokinase antisense RNA 1 (ADPGK-AS1) in BC progression remains undiscovered. Hence, this study aimed to investigate the role of ADPGK-AS1 in BC. qRT-PCR was performed to investigate ADPGK-AS1 expression level in BC tissues and cell lines. The effect of ADPGK-AS1 knockdown on BC cellular process was assessed by loss-of-function assay. Luciferase reporter and RIP assay were performed to investigate the combination between ADPGK-AS1 and miR-3196. The combination between miR-3196 and orthodenticle homeobox 1 (OTX1) was verified by luciferase reporter assay. Finally, rescue assays were performed to confirm the effects of ADPGK-AS1/miR-3196/OTX1 axis on BC development. ADPGK-AS1 expression level was upregulated in BC tissues and cell lines. High expression of ADPGK-AS1 predicted poor prognosis for BC patients. Functionally, ADPGK-AS1 promoted cell proliferation, migration, induced epithelial-mesenchymal transition (EMT) process, and suppressed cell apoptosis. Mechanistically, ADPGK-AS1 acted as a miR-3196 sponge to release OTX1 in BC cells. Currently, ADPGK-AS1 acted as a competing endogenous RNA (ceRNA) via modulating miR-3196/OTX1 axis in BC.
Similar content being viewed by others
References
Artibani M, Sims AH, Slight J, Aitken S, Thornburn A, Muir M, Brunton VG, Del-Pozo J, Morrison LR, Katz E, Hastie ND, Hohenstein P (2017) WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel. Sci Rep 7:45255
Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS (2016) In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer 122:1513–1522. https://doi.org/10.1002/cncr.29959
Cao C, Zhang T, Zhang D, Xie L, Zou X, Lei L, Wu D, Liu L (2016) The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene 36:1112–1122. https://doi.org/10.1038/onc.2016.278
Chen L, Jin Y, Wang L, Sun F, Yang X, Shi M, Zhan C, Shi Y, Wang Q (2017) Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma. Med Oncol 34(2):2
Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P, Chen Q, Wei C, Fu H, Xu T, Ren S, Wang Z, Sun M (2018a) Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer. Clin Cancer Res 24:2002–2014. https://doi.org/10.1158/1078-0432.ccr-17-2376
Chen X, Zeng K, Xu M, Hu X, Liu X, Xu T, He B, Pan Y, Sun H, Wang S (2018b) SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis. Cell Death Dis 9:982
Chen Y, Peng Y, Xu Z, Ge B, Xiang X, Zhang T, Gao L, Shi H, Wang C, Huang J (2018c) Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/beta-catenin pathway. Pathol Res Pract 215:302–307. https://doi.org/10.1016/j.prp.2018.11.015
Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou Z, Chang C, Qi J, Yeh S (2018) Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene 37:5037–5053. https://doi.org/10.1038/s41388-018-0175-6
Guo H, Zhao L, Shi B, Bao J, Zheng D, Zhou B, Shi J (2018) GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90. Oncogene 37:4505–4517
He J, Wu K, Guo C, Zhou JK, Pu W, Deng Y, Zuo Y, Zhao Y, Liu L, Wei YQ, Peng Y (2018) Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer. Cell Mol Life Sci 75:4667–4681. https://doi.org/10.1007/s00018-018-2923-8
Kwok ZH, Roche V, Chew XH, Fadieieva A, Tay Y (2018) A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers. Int J Cancer 143:668–678
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q, Cheng D, Chen H, Deng X, Peng C, Shen B (2017) Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer 16:169
Liang Y, Song X, Li Y, Sang Y, Zhang N, Zhang H, Liu Y, Duan Y, Chen B, Guo R, Zhao W, Wang L, Yang Q (2018) A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer. Cell Death Dis 9:563
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408
Lü MH, Tang B, Zeng S, Hu CJ, Xie R, Wu YY, Wang SM, He FT, Yang SM (2015) Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer. Oncogene 35:3524–3534. https://doi.org/10.1038/onc.2015.413
Ma S, Deng X, Yang Y, Zhang Q, Zhou T, Liu Z (2018) The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/beta-catenin signaling in cervical cancer. Biomed Pharmacother 108:1686–1693
Nishiyama K, Maruyama R, Niinuma T, Kai M, Kitajima H, Toyota M, Hatanaka Y, Igarashi T, Kobayashi JI, Ogi K, Dehari H, Miyazaki A, Yorozu A, Yamamoto E, Idogawa M, Sasaki Y, Sugai T, Tokino T, Hiratsuka H, Suzuki H (2018) Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1. Cell Death Dis 9:826
Pillar N, Polsky AL, Weissglas-Volkov D, Shomron N (2018) Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness. Cell Death Dis 9:1040
Polycarpou-Schwarz M, Gross M, Mestdagh P, Schott J, Grund SE, Hildenbrand C, Rom J, Aulmann S, Sinn HP, Vandesompele J, Diederichs S (2018) The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation. Oncogene 37:4750–4768
Qin SC, Zhao Z, Sheng JX, Xu XH, Yao J, Lu JJ, Chen B, Zhao GD, Wang XY, Yang YD (2018) Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion. Oncol Rep 40:1907–1916
Qiu ZL, Shen CT, Song HJ, Wei WJ, Luo QY (2015) Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study. Nucl Med Biol 42:499–504
Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG (2012) Expression of microRNAs in basal cell carcinoma. Br J Dermatol 167:847–855
Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H (2018) LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Cancer Biol Ther 19:573–583
Song YX, Sun JX, Zhao JH, Yang YC, Shi JX, Wu ZH, Chen XW, Gao P, Miao ZF, Wang ZN (2017) Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun 8:289
Sun Y, Zhou Y, Bai Y, Wang Q, Bao J, Luo Y, Guo Y, Guo L (2017) A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol Cancer 16:162
Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344–352
Terrinoni A, Pagani IS, Zucchi I, Chiaravalli AM, Serra V, Rovera F, Sirchia S, Dionigi G, Miozzo M, Frattini A, Ferrari A, Capella C, Pasquali F, Curto FL, Curto FL, Albertini A, Melino G, Porta G (2011) OTX1 expression in breast cancer is regulated by p53. Oncogene 30:3096–3103
Tian W, Du Y, Ma Y, Gu L, Zhou J, Deng D (2018) MALAT1-miR663a negative feedback loop in colon cancer cell functions through direct miRNA-lncRNA binding. Cell Death Dis 9:857
Wang X, Yu H, Sun W, Kong J, Zhang L, Tang J, Wang J, Xu E, Lai M, Zhang H (2018a) The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Mol Cancer 17:110
Wang Y, Sun L, Wang L, Liu Z, Li Q, Yao B, Wang C, Chen T, Tu K, Liu Q (2018b) Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/beta-catenin signal pathway in hepatocellular carcinoma. Cell Death Dis 9:851
Wang Y, Zhang X, Wang Z, Hu Q, Wu J, Li Y, Ren X, Wu T, Tao X, Chen X, Li X, Xia J, Cheng B (2018c) LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis. Cancer Lett 434:172–183
Wu DM, Wang S, Wen X, Han XR, Wang YJ, Shen M, Fan SH, Zhang ZF, Shan Q, Li MQ, Hu B, Lu J, Chen GQ, Zheng YL (2018) LncRNA SNHG15 acts as a ceRNA to regulate YAP1-hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis 9:947
Xu T, Lin CM, Cheng SQ, Min J, Li L, Meng XM, Huang C, Zhang L, Deng ZY, Li J (2018) Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star. Mol Cancer 17:103
Yan H, Rao J, Yuan J, Gao L, Huang W, Zhao L, Ren J (2017) Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway. Cell Death Dis 8:3211
Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G, Zhao Q, Wu D, Gong W, Du M, Chu H, Wang M, Zhang A, Zhang Z (2018a) LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer 17:87
Zhang JX, Chen ZH, Chen DL, Tian XP, Wang CY, Zhou ZW, Gao Y, Xu Y, Chen C, Zheng ZS, Weng HW, Ye S, Kuang M, Xie D, Peng S (2018b) LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis. Oncogene 37:2660–2675
Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, Sun M, Chen B, Zhao W, Wang L, Wang H, Moran MS, Haffty BG, Yang Q (2018c) SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with snail and HDAC1/2. Cell Death Differ 26:843–859. https://doi.org/10.1038/s41418-018-0158-8
Zhang S, Ma H, Zhang D, Xie S, Wang W, Li Q, Lin Z, Wang Y (2018d) LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death Dis 9:742
Zhou K, Zhang C, Yao H, Zhang X, Zhou Y, Che Y, Huang Y (2018a) Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132. Mol Cancer 17:105
Zhou YL, Sun Q, Zhang L, Li R (2018b) miR-208b targets Bax to protect H9c2 cells against hypoxia-induced apoptosis. Biomed Pharmacother 106:1751–1759
Zou M, Jin R, Au KF (2018) Revealing tumor heterogeneity of breast cancer by utilizing the linkage between somatic and germline mutations. Brief Bioinform. https://doi.org/10.1093/bib/bby084
Acknowledgements
The authors thank lab members.
Funding
This study was supported by the Individualized Endocrine Therapy for Luminal Breast Cancer (Fund number: 2015C0003), Effect of Autophagy on Anti-Breast Cancer of 2-Methoxyestradiol and its Mechanism (Fund number: 2018KY729) and Clinical and Curative Effects Prediction of Taxol with or without Carboplatin in the Adjuvant Chemotherapy of Triple-Negative Breast Cancer (Fund number: 2018KY724).
Author information
Authors and Affiliations
Contributions
Jiahui Yang and Weizhu Wu designed the research. Minhua Wu and Jinhua Ding collected materials. Jiahui Yang and Weizhu Wu performed experiments on cells. Minhua Wu and Jinhua Ding recorded the experimental results. All authors contributed to data analysis and article writing.
Corresponding author
Ethics declarations
This project was approved by the Ethics Committee of the Department of Thyroid and Breast, Ningbo Medical Center Lihuili Eastern Hospital/Taipei Medical University Ningbo Medical Center; all patients had signed the written informed consents before study.
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Editor: Tetsuji Okamoto
Jiahui Yang and Weizhu Wu co-first author
Electronic supplementary material
Supplementary Figure 1
A. Overexpression efficiency for ADPGK-AS1 in MDA-MB-453 and MCF-7 cells. B-C. Cell proliferation was measured by cell proliferation assay and colony formation assay after transfection with ADPGK-AS1 expression vector or empty vector. D. Overexpression efficiency for OTX1 in MDA-MB-453 and MCF-7 cells. E-F. The effect of OTX1 overexpression on cell proliferation was detected by cell proliferation assay and colony formation assay. G. Luciferase activity of miR-3196-WT or miR-3196-MUT was measured after transfection with NC or ADPGK-AS1 expression vector. *p < 0.05, **p < 0.01, ***p < 0.001 vs control group. (PNG 441 kb)
Rights and permissions
About this article
Cite this article
Yang, J., Wu, W., Wu, M. et al. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer. In Vitro Cell.Dev.Biol.-Animal 55, 522–532 (2019). https://doi.org/10.1007/s11626-019-00372-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-019-00372-1